Nursing care
Nitrofurantoin: what to check before you give it
Written and reviewed by Dana Whitfield, RN, MSN · 3 min read · Updated September 2026
Short answer
Nitrofurantoin is a urinary antiseptic used for uncomplicated cystitis. It concentrates in the bladder but does not reach therapeutic levels in kidney tissue, so it is the wrong choice for pyelonephritis. Expect harmless brown urine discolouration and take the drug with food to reduce GI upset and improve absorption.
Mechanism, simply
Nitrofurantoin is reduced by bacterial enzymes into reactive intermediates that attack ribosomal proteins, DNA, and other essential bacterial molecules simultaneously. This broad, multi-target damage is why resistance develops slowly compared with many other antibiotics.
The drug is rapidly absorbed and then rapidly excreted unchanged into the urine, which is exactly where it needs to be. Blood levels stay low, so it never builds the systemic concentration needed to treat infection outside the urinary tract.
Indications you will see on the ward
Nitrofurantoin is first-line for uncomplicated lower urinary tract infection, acute cystitis, and it is also used for UTI prophylaxis in patients with recurrent infections. You will see it prescribed in pregnancy for cystitis, avoided near term because of a small risk of neonatal haemolytic anaemia close to delivery.
It is not indicated for pyelonephritis, prostatitis, or any infection outside the bladder, and it should not be used in patients with significantly reduced renal function, because it will not reach effective concentration in the urine and toxicity risk rises.
Assessment before administration
Check renal function before starting; nitrofurantoin is generally avoided when creatinine clearance falls below roughly 30 to 60 mL/min depending on the reference used, because impaired kidneys cannot concentrate the drug in urine and systemic toxicity risk increases.
Ask about G6PD deficiency, since nitrofurantoin can trigger haemolytic anaemia in these patients, and review baseline pulmonary and hepatic status if the patient will be on a long-term prophylactic course. Confirm the infection is confined to the lower urinary tract before administering, since flank pain or fever suggests pyelonephritis and a different drug is needed.
Toxicity and the antidote
There is no specific antidote. Acute pulmonary reactions, fever, chills, cough, and dyspnea can occur within hours of a dose and require immediate discontinuation. Chronic pulmonary toxicity develops with long-term use and presents more insidiously as progressive dyspnea and interstitial changes.
Hepatotoxicity and peripheral neuropathy are also recognised with prolonged therapy. Management is supportive: stop the drug at the first sign of pulmonary or hepatic symptoms, and monitor respiratory and liver function until resolution.
Interactions that matter
Antacids containing magnesium trisilicate reduce nitrofurantoin absorption and should be avoided close to dosing. Probenecid and sulfinpyrazone reduce renal tubular secretion of nitrofurantoin, lowering urinary concentration and raising blood levels, which undermines the drug's whole mechanism of action.
Fluoroquinolones can antagonise nitrofurantoin's antibacterial effect in vitro, so the two are not typically combined. There is no interaction with alcohol comparable to metronidazole, which is a useful distinguishing point on exams.
What the patient must be told
Urine may turn brown or dark yellow during treatment; this is harmless and expected, not a sign of liver injury or blood in the urine. Take the medication with food or milk to reduce nausea and improve absorption.
Complete the full course even if symptoms improve within a day or two. Report any new cough, shortness of breath, or chest tightness immediately, since these can signal a pulmonary reaction. This drug treats the bladder only; if fever, chills, or flank pain develop, that suggests the infection has moved to the kidney and needs different treatment.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our pharmacology practice questions are the closest set to what this page covers.
One question from the pharmacology set
A client with heart failure is started on furosemide 40 mg PO daily. Which findings should the nurse report to the provider before administering the next dose? Select all that apply.
Rationale
Furosemide is a loop diuretic, so the two things you are watching are potassium and kidney function. A potassium of 2.9 mEq/L is below the 3.5–5.0 reference range and puts the client at risk for dysrhythmia — hold and report. Muscle cramps with palpitations are the clinical face of that same hypokalemia, so they are reported together, not separately. A creatinine that doubles signals the diuresis has outrun renal perfusion. A blood pressure of 132/78 and a 1 kg loss are the expected response to the drug working, not reasons to hold it.
Answer: A, D, E
Common questions
Can nitrofurantoin treat a kidney infection?
No. Nitrofurantoin does not achieve therapeutic tissue concentrations in the kidney, so it is not used for pyelonephritis. It is effective only for infections confined to the bladder.
Is brown urine from nitrofurantoin a sign of a problem?
No, it is an expected and harmless effect of the drug's metabolites. It resolves once the course is finished and does not indicate kidney or liver injury.
Why is nitrofurantoin avoided in reduced kidney function?
The drug depends on being concentrated in the urine to work, and impaired kidneys cannot achieve that concentration. This raises the risk of systemic accumulation and toxicity while reducing effectiveness against the infection.
What pulmonary symptoms should stop a patient's next dose of nitrofurantoin?
New or worsening cough, shortness of breath, fever, or chest tightness can indicate an acute pulmonary hypersensitivity reaction. The dose should be held and the prescriber notified promptly.
More on pharmacology
Guides on this